
Peptides
Peptides are short chains of amino acids linked by peptide bonds, serving as important biological molecules that play key roles in cellular processes. They function as hormones, neurotransmitters, and signaling molecules, and are widely used in therapeutic and diagnostic applications. Peptides are also crucial in research for studying protein interactions, enzyme activities, and cell signaling pathways. At CymitQuimica, we provide a diverse selection of high-quality peptides to support your research and development needs in biotechnology and pharmaceuticals.
Subcategories of "Peptides"
Products of "Peptides"
Sort by
H-FLYDRLAST-0H
Peptide H-FLYDRLAST-0H is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FLYDRLAST-0H include the following: Development of Ebola Vaccine Candidate by in Silico from Glikoprotein (GP) Gene of Ebola Zaire Virus Y Suryani , O Taupiqurrohman , S Aryanti - Journal of Physics , 2018 - iopscience.iop.orghttps://iopscience.iop.org/article/10.1088/1742-6596/1090/1/012081/meta B and T cell epitope-based peptides predicted from evolutionarily conserved and whole protein sequences of Ebola virus as vaccine targets T Yasmin , AHMN Nabi - Scandinavian journal of immunology, 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/sji.12425 Analisis in silico gen glikoprotein (GP) virus zaire ebola dan sudan ebola untuk vaksin ebola S Aryanti - 2017 - digilib.uinsgd.ac.idhttps://digilib.uinsgd.ac.id/19525/ Prediction of epitope-based peptides for vaccine development from coat proteins GP2 and VP24 of Ebola virus using immunoinformatics PN Srivastava , R Jain , SD Dubey , S Bhatnagar - journal of peptide , 2016 - Springerhttps://link.springer.com/article/10.1007/s10989-015-9492-6 Prediction and conservancy analysis of promiscuous T-cell binding epitopes of Ebola virus L protein: an in silico approach G Ayub, Y Waheed , MH Najmi - Asian Pacific Journal of Tropical Disease, 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2222180815610076 Multi epitope peptide vaccine prediction against Sudan Ebola virus using immuno-informatics approaches AH Abu-Haraz, KA Abd-elrahman, MS Ibrahim - Adv Tech Biol , 2017 - researchgate.nethttps://www.researchgate.net/profile/Mohamed-Hassan-36/publication/315063611_Multi_Epitope_Peptide_Vaccine_Prediction_against_Sudan_Ebola_Virus_Using_Immuno-Informatics_Approaches/links/58d3ca57aca2723c0a79c74e/Multi-Epitope-Peptide-Vaccine-Prediction-against-Sudan-Ebola-Virus-Using-Immuno-Informatics-Approaches.pdfATP6AP1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ATP6AP1 antibody, catalog no. 70R-4520Purity:Min. 95%UBE2E2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of UBE2E2 antibody, catalog no. 70R-2819Purity:Min. 95%N,N,N',N'-Tetramethyl-S-(1-oxido-2-pyridyl)thiouronium Hexafluorophosphate
CAS:Formula:C10H16F6N3OPSPurity:>98.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:371.28Ac-IPESSELTLQELLGEERR-NH2
Peptide Ac-IPESSELTLQELLGEERR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-IPESSELTLQELLGEERR-NH2 include the following: Evaluation of Different Glutathione S-Transferase-Tagged Protein Captures for Screening E6/E6AP Interaction Inhibitors Using AlphaScreen® P Sehr, M Pawlita, J Lewis - SLAS Discovery, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2472555222083526 Association strength of E6 to E6AP/p53 complex correlates with HPV-mediated oncogenesis risk MVF Ferraz , IFT Viana , DF Coacaªlho , CHB da Cruz - , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bip.23524 A novel missense mutation of the ubiquitin protein ligase E3A gene in a patient with Angelman syndrome J Bai, YJ Qu, L Zou, X Yang, L Liu - Chinese Medical Journal, 2011 - mednexus.orghttps://mednexus.org/doi/abs/10.3760/cma.j.issn.0366-6999.2011.01.016 Is viral E6 oncoprotein a viable target? A critical analysis in the context of cervical cancer A Kumar , E Rathi , RC Hariharapura - Medicinal research , 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/med.21697IDS Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of IDS antibody, catalog no. 70R-10208Purity:Min. 95%Ala-Tyr-Ser-Ser-Gly-Ala-Pro-Pro-Met-Pro-Pro-Phe-Pr
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolFormula:C103H145N23O36S1Molecular weight:2,313.45 g/molDPP3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DPP3 antibody, catalog no. 70R-3626Purity:Min. 95%NGRN Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NGRN antibody, catalog no. 70R-2619Purity:Min. 95%Ribophorin I Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RPN1 antibody, catalog no. 70R-7110Purity:Min. 95%H-TTPPMLDSDGSFFLYSK^-OH
Peptide H-TTPPMLDSDGSFFLYSK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TTPPMLDSDGSFFLYSK^-OH include the following: Search Type Combined MS/MS-ProteinExtractor Search Result Amazon Human_SPJuly2013_2016-08-08 18: 23: 29 Search Location/Kathir/ABC 2016 IgG P Score - pure.mpg.dehttps://pure.mpg.de/pubman/item/item_2368678_11/component/file_2368701/2368678_supp2.pdf?mode=download Absolute and multiplex quantification of antibodies in serum using PSAQâ¢standards and LC-MS/MS D Lebert, G Picard, C Beau-Larvor, L Troncy - Bioanalysis, 2015 - Future Sciencehttps://www.future-science.com/doi/abs/10.4155/bio.15.563-(2-Naphthyl)-L-alanine Hydrochloride
CAS:Formula:C13H13NO2·HClPurity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:251.71H-DRVAIHPF-OH
Peptide H-DRVAIHPF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DRVAIHPF-OH include the following: Intracellular photocatalytic-proximity labeling for profiling protein-protein interactions in microenvironments M Tsushima, S Sato, K Miura , T Niwa - Chemical , 2022 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2022/cc/d1cc05764b BODIPY Catalyzes Proximity-Dependent Histidine Labelling K Nakane, T Niwa, M Tsushima, S Tomoshige - , 2022 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cctc.202200077 Proximity histidine labeling by umpolung strategy using singlet oxygen K Nakane, S Sato, T Niwa, M Tsushima - Journal of the , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jacs.1c01626Ac-Leu-Leu-Nle-H (Aldehyde)
CAS:Ac-Leu-Leu-Nle-H (Aldehyde) is a Toll-like receptor ligand that is active against bowel disease. Aldehyde has been shown to have chemotherapeutic effects in vitro and in vivo, even at low doses. It also inhibits the growth of certain cancer cells by inducing apoptosis, which may be due to its ability to activate the nuclear factor kappa B/Toll-like receptor pathway. This agent has been shown to bind to DNA, inhibit transcription, and induce programmed cell death. Aldehyde also binds to proteins that are involved in protein synthesis and cell division. These properties make it useful for the treatment of infectious diseases and cancer.Formula:C20H37N3O4Purity:Min. 95%Molecular weight:383.54 g/molH-YEPQAPWMEQ-OH
Peptide H-YEPQAPWMEQ-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YEPQAPWMEQ-OH include the following: Manuscript Information TH Hansen, DHMZIA AI000394 - academia.eduhttps://www.academia.edu/download/43891016/A_structural_and_molecular_dynamics_appr20160319-28582-12vf0ct.pdf The Peptide-Receptive Transition State of NBM Natarajan, TH Hansen, H David, MJR Boyd - 2012 - academia.eduhttps://www.academia.edu/download/43890997/The_Peptide-Receptive_Transition_State_o20160319-21209-1oas038.pdf The peptide-receptive transition state of MHC class I molecules: insight from structure and molecular dynamics MG Mage, MA Dolan, R Wang, LF Boyd - The Journal of , 2012 - journals.aai.orghttps://journals.aai.org/jimmunol/article/189/3/1391/83449 A structural and molecular dynamics approach to understanding the peptide-receptive transition state of MHC-I molecules MG Mage, MA Dolan, R Wang, LF Boyd - Molecular , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S016158901200435XC1QA Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C1QA antibody, catalog no. 70R-9974Purity:Min. 95%L-Tyrosine, N-[(phenylmethoxy)carbonyl]-
CAS:Formula:C17H17NO5Purity:98%Color and Shape:SolidMolecular weight:315.3206GATM Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GATM antibody, catalog no. 70R-2511Purity:Min. 95%C19ORF28 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C19orf28 antibody, catalog no. 70R-6785Purity:Min. 95%TMEM117 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TMEM117 antibody, catalog no. 70R-7032Purity:Min. 95%TNP-ATP triethylammonium salt
CAS:P2X receptor antagonistFormula:C40H77N12O19P3Purity:98%Color and Shape:SolidMolecular weight:1123.042N-Carbobenzoxy-D-leucine Dicyclohexylammonium Salt
CAS:Formula:C14H19NO4·C12H23NPurity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:446.63Defensin-1 (human) HNP-1
CAS:Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolFormula:C150H222N44O38S6Molecular weight:3,442.1 g/molERC1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ERC1 antibody, catalog no. 70R-9796Purity:Min. 95%Pep 2-8 ammonium salt(1541011-97-5 free base)
Pep 2-8 ammonium salt inhibits PCSK9-LDL receptor binding (IC50 = 0.8 μM), boosting LDL uptake in HepG2 cells.Formula:C83H113N17O24Purity:95.76% - 99.87%Color and Shape:SolidMolecular weight:1732.91H-MVWESGCTV-OH
Peptide H-MVWESGCTV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-MVWESGCTV-OH include the following: Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8+ T cells and exhibit a distinct CD95hi B cell phenotype SJ Hanna, WE Powell, AE Long , EJS Robinson - Diabetologia, 2020 - Springerhttps://link.springer.com/article/10.1007/s00125-020-05114-7 Cytotoxic T cells to an epitope in the islet autoantigen IA-2 are not disease-specific K Takahashi , MC Honeyman, LC Harrison - Clinical Immunology, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1521661601950314Ac-Leu-Val-Ser-Arg-AMC
Ac-Leu-Val-Ser-Arg-MCA is a peptide that has been identified as a potential MALT1 substrate. It is a small, cationic peptide with a molecular weight of 1,261. Ac-Leu-Val-Ser-Arg-MCA binds to the active site of MALT1 and inhibits its activity by binding to the zinc atom in the enzyme's active site. Ac-Leu-Val-Ser-Arg-MCA also prevents bacterial adhesion to epithelial cells and decreases inflammatory cytokines such as IL1β and TNFα.Formula:C32H48N8O8Purity:Min. 95%Molecular weight:672.79 g/molZIP
CAS:Novel inhibitor for PKMζ, halts synaptic potentiation and reverses LTP with IC50 of 1-2.5 μM, erasing spatial memory.Formula:C90H154N30O17Purity:98%Color and Shape:SolidMolecular weight:1928.4CGGRGD TFA (1260223-44-6 free base)
CGGRGD TFA synthesized via solid-phase synthesis; PCL fibers aminolysed with amino 2-cyanobenzothiazole, then CBT added.Formula:C21H34F3N9O11SPurity:98%Color and Shape:SolidMolecular weight:677.61Fmoc-Leu-Gly-OH
CAS:Fmoc-Leu-Gly-OH is a dipeptide that is reversibly soluble in water and organic solvents. It has been found to be stable at millimeter and nanometer scales, which makes it suitable for use as a hydrogel or fiber. Fmoc-Leu-Gly-OH has also been shown to form membranes of variable thickness (from micrometers to nanometers) that are sensitive to pH changes. This means that the membrane can be used for sensing pH levels in a variety of environments. Dipeptides are amphiphiles, meaning they have both hydrophilic and lipophilic properties. This makes them useful for forming self-assembled structures, such as hydrogels and membranes, that are capable of transporting water molecules through the structure.Formula:C23H26N2O5Purity:Min. 95%Color and Shape:PowderMolecular weight:410.46 g/molH-VLIGLDLLYGELQDSDDF-OH
Peptide H-VLIGLDLLYGELQDSDDF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VLIGLDLLYGELQDSDDF-OH include the following: Absolute quantitation of proteins by coulometric mass spectrometry P Zhao , Q Wang , M Kaur , YI Kim , HD Dewald - Analytical , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.0c01151 Novel Applications of Mass Spectrometry for Quantitation and Reaction Mechanism Elucidation P Zhao - 2020 - search.proquest.comhttps://search.proquest.com/openview/b31b3dcc5e960dd07a2e5cd97517b470/1?pq-origsite=gscholar&cbl=18750&diss=yH-RKRTLRRL-OH
Peptide H-RKRTLRRL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RKRTLRRL-OH include the following: Protein kinase C betaII activation induces angiotensin converting enzyme expression in neonatal rat cardiomyocytes Y Zhang, LJ Bloem, L Yu, TB Estridge - Cardiovascular , 2003 - academic.oup.comhttps://academic.oup.com/cardiovascres/article-abstract/57/1/139/373511 Purification and characterization of protein kinase C from the nematode Caenorhabditis elegans T Sassa, J Miwa - Biochemical Journal, 1992 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/282/1/219/36669 Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium SA Rotenberg, S Smiley , M Ueffing , RS Krauss - Cancer research, 1990 - AACRhttps://aacrjournals.org/cancerres/article-abstract/50/3/677/496085 Biophysical studies of lipopeptide-membrane interactions RM Epand - Peptide Science, 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0282(1997)43:1%3C15::AID-BIP3%3E3.0.CO;2-3 Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy RA Kowluru , RL Engerman , TS Kern - Free Radical Research, 2000 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/10715760000300071 Selective recognition of phosphatidylinositol 3, 4, 5-trisphosphate by a synthetic peptide PJ Lu , CS Chen - Journal of Biological Chemistry, 1997 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)78616-5/abstract Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. P Xia, LP Aiello , H Ishii, ZY Jiang - The Journal of , 1996 - Am Soc Clin Investighttps://www.jci.org/articles/view/119006 Overexpression of protein kinase C alpha and beta1 has distinct effects on bovine aortic endothelial cell growth OR Rosales, CM Isales , J Bhargava - Cellular signalling, 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0898656898000023 Inhibition of protein kinase C by a synthetic peptide corresponding to cytoplasmic domain residues 828-848 of the human immunodeficiency virus type 1 envelope NE Ward, KR Gravitt, CA O'Brian - Cancer letters, 1995 - Elsevierhttps://www.sciencedirect.com/science/article/pii/030438359403610U A peptide substrate-based affinity label blocks protein kinase C-catalyzed ATP hydrolysis and peptide-substrate phosphorylation NE Ward, DS Pierce, JR Stewart, CA O'Brian - Archives of biochemistry and , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003986199911645 Increased Protein Kinase C Activity and Expression of Ca2+-Sensitive Isoforms in the Failing Human Heart N Bowling, RA Walsh, G Song, T Estridge - Circulation, 1999 - Am Heart Assochttps://www.ahajournals.org/doi/abs/10.1161/01.CIR.99.3.384 Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective LP Aiello , SE Bursell, A Clermont, E Duh , H Ishii - Diabetes, 1997 - Am Diabetes Assochttps://diabetesjournals.org/diabetes/article-abstract/46/9/1473/9831 Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes L Calaca² , G Ceolotto , M Milani, E Pagnin - Kidney international, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0085253815479438 Selective translocation of protein kinase C-delta in PC12 cells during nerve growth factor-induced neuritogenesis. KR O'driscoll, KK Teng, D Fabbro - Molecular biology of , 1995 - Am Soc Cell Biolhttps://www.molbiolcell.org/doi/abs/10.1091/mbc.6.4.449 Characteristic changes in protein-kinase-C activity and isoforms in ah66 cells during the acquisition of multidrug-resistant phenotype K Ohkawa, T Hatano, S Isonishi - Oncology , 1994 - spandidos-publications.comhttps://www.spandidos-publications.com/or/1/3/551 Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance K Naruse, C Rask-Madsen , N Takahara, S Ha - Diabetes, 2006 - Am Diabetes Assochttps://diabetesjournals.org/diabetes/article-abstract/55/3/691/12765 Oleic acid induces endothelin-1 expression through activation of protein kinase C and NF-κB JY Park, YM Kim, HS Song, KY Park, YM Kim - Biochemical and , 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X03004364 Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. JY Park, N Takahara, A Gabriele, E Chou, K Naruse - Diabetes, 2000 - Am Diabetes Assochttps://diabetesjournals.org/diabetes/article-abstract/49/7/1239/12202 Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle JD Chang, Y Xu, MK Raychowdhury - Journal of Biological , 1993 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)85228-6/abstract Inhibition of Platelet Integrin alphaIIbbeta3 by Peptides That Interfere With Protein Kinases and the beta3 Tail I Hers, J Donath, PEMH Litjens - and Vascular Biology, 2000 - Am Heart Assochttps://www.ahajournals.org/doi/abs/10.1161/01.atv.20.6.1651 Overproduction of protein kinase C causesdisordered growth control in rat fibroblasts GM Housey, MD Johnson, WLW Hsiao, CA O'Brian - Cell, 1988 - cell.comhttps://www.cell.com/cell/pdf/S0092-8674(88)80027-8.pdf Structural and functional studies of protein kinase C GM Housey, MD Johnson, WLW Hsiao - Biology of Growth , 1988 - Springerhttps://link.springer.com/chapter/10.1007/978-1-4757-1980-2_10 Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4, 5-bisphosphate coordinately regulate protein kinase C activity ES Oh, A Woods, ST Lim , AW Theibert - Journal of Biological , 1998 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)44779-5/abstract Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C ES Oh, A Woods, JR Couchman - Journal of Biological Chemistry, 1997 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)40520-0/abstract Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and D Koya, MR Jirousek, YW Lin, H Ishii - The Journal of , 1997 - Am Soc Clin Investighttps://www.jci.org/articles/view/119503 A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycin CA O'Brian, NE Ward, RM Liskamp , DB de Bont - Investigational new , 1991 - Springerhttps://link.springer.com/article/10.1007/BF00175084 Irreversible Inactivation of Protein Kinase C Isozymes by Thiol-Reactive Peptide Substrate Analogs CA O'Brian, NE Ward, F Chu, JR Stewart - Protein Kinase C Protocols, 2003 - Springerhttps://link.springer.com/protocol/10.1385/1-59259-397-6:441 Protein kinase C-activated oxidant generation in endothelial cells signals intercellular adhesion molecule-1 gene transcription A Rahman , M Bando, J Kefer, KN Anwar - Molecular pharmacology, 1999 - ASPEThttps://molpharm.aspetjournals.org/content/55/3/575.short Derivatisation of arginine residues with malondialdehyde for the analysis of peptides and protein digests by LC-ESI-MS/MS A Foettinger, A Leitner - Journal of mass , 2006 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/jms.1020H-EGMNIVEAMER-OH
Peptide H-EGMNIVEAMER-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EGMNIVEAMER-OH include the following: Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy M Holderfield, BJ Lee, J Jiang, A Tomlinson - Nature, 2024 - nature.comhttps://www.nature.com/articles/s41586-024-07205-6 Thermostability-assisted limited proteolysis-coupled mass spectrometry for capturing drug target proteins and sites L Yang, CW Guo, QM Luo, ZF Guo, L Chen - Analytica Chimica , 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003267024005567 Development of a Novel Tracer-based Metabolomics Methodology to Study the Metabolism of Cancer Cells K Misuno - 2017 - search.proquest.comhttps://search.proquest.com/openview/9c91027650b317f174b21849ec913496/1?pq-origsite=gscholar&cbl=18750H-NWRAMASDFNLPPVV-OH
Peptide H-NWRAMASDFNLPPVV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NWRAMASDFNLPPVV-OH include the following: Exploring T & B-cell epitopes and designing multi-epitope subunit vaccine targeting integration step of HIV-1 lifecycle using immunoinformatics approach F Abdulla , UK Adhikari , MK Uddin - Microbial pathogenesis, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0882401019301329H-WDDR-OH
Peptide H-WDDR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-WDDR-OH include the following: Study of secondary specificity of enteropeptidase in comparison with trypsin AG Mikhailova, VV Likhareva, BV Vaskovsky - Biochemistry , 2004 - Springerhttps://link.springer.com/article/10.1023/B:BIRY.0000040224.47278.3bH-VEEVSLRK^-OH
Peptide H-VEEVSLRK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VEEVSLRK^-OH include the following: Genetic alterations and checkpoint expression: mechanisms and models for drug discovery S Ding, S Li, S Zhang, Y Li - Regulation of Cancer Immune Checkpoints , 2020 - Springerhttps://link.springer.com/chapter/10.1007/978-981-15-3266-5_10 HLA class I genotype Is associated with relapse risk after allogeneic stem cell transplantation for NPM1-mutated acute myeloid leukemia R Narayan, A Niroula , T Wang, M Kuxhausen - and cellular therapy, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2666636723012046 Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia DI van der Lee, RM Reijmers - The Journal of , 2019 - Am Soc Clin Investighttps://www.jci.org/articles/view/97482MMP-8 Substrate, fluorogenic
Catalogue peptide; min. 95% purityFormula:C49H63N13O13Molecular weight:1,042.14 g/molTGFB1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TGFB1 antibody, catalog no. 70R-8230Purity:Min. 95%4A/4B, Peptide (1)
Catalogue peptide; min. 95% purityFormula:C67H100N16O25S2Molecular weight:1,593.76 g/molH-ELTR-NH2
Peptide H-ELTR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ELTR-NH2 include the following: Liver transplantation trends and outcomes for hereditary hemorrhagic telangiectasia in the United States VN Iyer, B Saberi , JK Heimbach, JJ Larson - , 2019 - journals.lww.comhttps://journals.lww.com/transplantjournal/fulltext/2019/07000/liver_transplantation_trends_and_outcomes_for.23.aspx Primary structure and functional expression of human Glycyl-tRNA synthetase, an autoantigen in myositis. Q Ge, EP Trieu, IN Targoff - Journal of Biological Chemistry, 1994 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)61975-7/abstract Liver transplantation versus liver resection for treatment of neuroendocrine liver metastasis: Appraisal of the current evidence PC Muller , M Pfister, D Eshmuminov - Hepatobiliary & Pancreatic , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1499387223001261 Application of a proteomic approach to identify proteins associated with primary graft non-function after liver transplantation O Kornasiewicz, K Bojarczuk - International , 2012 - spandidos-publications.comhttps://www.spandidos-publications.com/ijmm/30/4/755 Fishing for vaccines against Vibrio cholerae using in silico pan-proteomic reverse vaccinology approach MI Rashid , S Rehman, A Ali , S Andleeb - PeerJ, 2019 - peerj.comhttps://peerj.com/articles/6223/ Liver transplantation in the treatment of unresectable hepatic metastasis from neuroendocrine tumors J Kim , MA Zimmerman , JC Hong - Journal of Gastrointestinal , 2020 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340808/ AD'-260199 ATION PAGE IA UE - EXPERIMENTAL. PARASITOLOGY, 1992 - apps.dtic.milhttps://apps.dtic.mil/sti/pdfs/ADA260199.pdf Association of Hemolytic Activity of Pseudomonas entomophila, a Versatile Soil Bacterium, with Cyclic Lipopeptide Production I Vallet-Gely, A Novikov, L Augusto - Applied and , 2010 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/aem.02112-09 Effect of Thyroid Activity Modulation on Some Histological and Biochemical Aspects in Broiler Chicks I Elwardany , EF EL DALY, AH ABD EL GAWAD - 2012 - sid.irhttps://www.sid.ir/paper/593090/fa MK ANGELE and FW SCHILDBERG, in cooperation with the Munich Liver Transplant Group HG RAU, R SCHAUER, M STANGL - Hepatology , 2000 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=CxaSFFO67VAC&oi=fnd&pg=PA345&dq=(%22ELTR%22+OR+%22H-ELTR-NH2%22)+AND+peptide&ots=nMVI6bv8Z5&sig=OR1yK3VNIupKvbxaLxFg0Xc6MSc Liver transplantation in gastroenteropancreatic neuroendocrine tumors ESM Fernandes , CVG Kyt, FPT de Mello - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fonc.2022.1001163/full A system capable of verifiably and privately screening global DNA synthesis C Baum , J Berlips, W Chen, H Cui, I Damgard - arXiv preprint arXiv , 2024 - arxiv.orghttps://arxiv.org/abs/2403.14023S-Acetyl-dPEG®8-OH
CAS:S-Acetyl-dPEG®8-OH is a PEG polymer categorised as monofunctional (OH-PEG-X). Used as a linker, S-Acetyl-dPEG®8-OH is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.Formula:C18H36O9SPurity:Min. 95%Molecular weight:428.54 g/molH-AVVGILLVV-OH
Peptide H-AVVGILLVV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AVVGILLVV-OH include the following: In silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancer U Baloria, BA Akhoon , SK Gupta , S Sharma, V Verma - Amino acids, 2012 - Springerhttps://link.springer.com/article/10.1007/s00726-010-0830-x HER-2/neu (657-665) represents an immunogenic epitope of HER-2/neu oncoprotein with potent antitumor properties AD Gritzapis , A Fridman , SA Perez , N La Monica - Vaccine, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X09014510PKCε (85-92)
CAS:PKCε (85-92) is a biologically active peptide that functions as a specific activator of ε-PKC and induces MARCKS phosphorylation in wild-type cells, but doesFormula:C39H54N10O14Purity:98%Color and Shape:SolidMolecular weight:886.9m-dPEG®36-Azide (Azido-m-dPEG®36)
CAS:m-dPEG®36-Azide (Azido-m-dPEG®36) is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. m-dPEG®36-Azide (Azido-m-dPEG®36) is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Purity:Min. 95%Molecular weight:1,642.95 g/molH-CTASNKNRGIIKTFS-OH
Peptide H-CTASNKNRGIIKTFS-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CTASNKNRGIIKTFS-OH include the following: Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches SJ Wu, A Schmidt, EJ Beil, ND Day - Journal of general , 2007 - microbiologyresearch.orghttps://www.microbiologyresearch.org/content/journal/jgv/10.1099/vir.0.82753-0Boc-L-4-fluorophenylalanine
CAS:Formula:C14H18FNO4Purity:98%Color and Shape:SolidMolecular weight:283.2954Ac-DTSHARPPGPGRALLEC-NH2 PAB-403-465B
Peptide Ac-DTSHARPPGPGRALLEC-NH2 PAB-403-465B is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-DTSHARPPGPGRALLEC-NH2 PAB-403-465B include the following: SLC2A9 is a high-capacity urate transporter in humans MJ Caulfield , PB Munroe , D O'Neill, K Witkowska - PLoS , 2008 - journals.plos.orghttps://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0050197 Asymmetric syncytial expression of GLUT9 splice variants in human term placenta and alterations in diabetic pregnancies KP Bibee, NP Illsley , KH Moley - Reproductive sciences, 2011 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/19337191103802766-FAM-AEEAC-SHK TFA
6-FAM-AEEAC-SHK TFA, a peptide neurotoxin derived from Stichodactyla helianthus and conjugated with a fluorescent marker, selectively blocks voltage-gated potassium channels (kv1.1 and kv1.2). By prolonging action potentials, it interferes with neural signal conduction, making it valuable in neuroscience research.Formula:C196H295N55O57S7·xCHF3O2Color and Shape:SolidMolecular weight:4558.23 (free acid)EVI2A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EVI2A antibody, catalog no. 70R-8010Purity:Min. 95%H-DLISNINVIVLELK^-OH
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolBax inhibitor peptide V5
CAS:Bax inhibitor peptide V5 (BIP-V5) is a Bax-mediated apoptosis inhibitor with anticancer activity.Formula:C27H50N6O6SColor and Shape:SolidMolecular weight:586.79H-VMAPRTLFL-OH
Peptide H-VMAPRTLFL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VMAPRTLFL-OH include the following: Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8+ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA WC Pump, T Kraemer, T Huyton, GGT Haca² - International Journal of , 2019 - mdpi.comhttps://www.mdpi.com/1422-0067/20/6/1454 HLA-E: a novel player for histocompatibility T Kraemer, R Blasczyk - Journal of Immunology , 2014 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2014/352160 HLA-E: presentation of a broader peptide repertoire impacts the cellular immune response-implications on HSCT outcome T Kraemer, AA Celik, T Huyton - Stem cells , 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2015/346714 Peptide selectivity discriminates NK cells from KIR2DL2-and KIR2DL3-positive individuals S Cassidy, S Mukherjee, TM Myint - European journal of , 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201444613 Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells Q Hammer , T Ruckert , EM Borst, J Dunst - Nature , 2018 - nature.comhttps://www.nature.com/articles/s41590-018-0082-6 Human T cell receptor-mediated recognition of HLA-E P GarcacaÂa, M Llano , AB Heredia - European journal of , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4141(200204)32:4%3C936::AID-IMMU936%3E3.0.CO;2-M Electrophile scanning reveals reactivity hotspots for the design of covalent peptide binders NM Grob , C Remarcik , SL RoÃËssler - ACS Chemical , 2023 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acschembio.3c00538 HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences N Lee, DR Goodlett , A Ishitani, H Marquardt - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/160/10/4951/69107 Unveiling a novel NKG2A inhibitor based on monoclonal antibody to HLAE-peptide complex. MK Abu Ahmad, O Radinsky, A Porgador , F Momburg - 2024 - ascopubs.orghttps://ascopubs.org/doi/abs/10.1200/JCO.2024.42.16_suppl.e14677 Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and down-regulates natural killer cell-mediated swine endothelial cell lysis1 K Matsunami, S Miyagawa, R Nakai, M Yamada - , 2002 - journals.lww.comhttps://journals.lww.com/transplantjournal/fulltext/2002/05270/Modulation_of_the_leader_peptide_sequence_of_the.10.aspx Identification of amino acid positions involved in HLA-E expression K Matsunami, E Okura, H Uchida, H Otsuka - Journal of , 2008 - academic.oup.comhttps://academic.oup.com/jb/article-abstract/143/5/641/774294 Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2 JD Miller, DA Weber, C Ibegbu, J Pohl - The Journal of , 2003 - journals.aai.orghttps://journals.aai.org/jimmunol/article/171/3/1369/973 Analysis of HLA-E Peptide-Binding Specificity JD Altman , PE Jensen, JD Miller, DA Weber, C Ibegbu - J Immunol, 2003 - academia.eduhttps://www.academia.edu/download/40078875/Analysis_of_HLA-E_peptide-binding_specif20151116-18223-1t98kb0.pdf NK cells: tuned by peptide? J Das , SI Khakoo - Immunological reviews, 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/IMR.12315 Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors HL Hoare, LC Sullivan , CS Clements, LK Ely - Journal of molecular , 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022283608001770 HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells G Pietra , C Romagnani, L Moretta - Current , 2009 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2009/00000015/00000028/art00014 What a difference an amino acid makes: An all-atom simulation study of nonameric peptides in inhibitory HLA-E/NKG2A/CD94 immune complexes E PraÅ¡nikar, A Perdih , J BoriÅ¡ek - Frontiers in Pharmacology, 2022 - frontiersin.orghttps://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.925427 HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection D Tarrago Asensio, I Gonzalez-Jimenez - 2022 - repisalud.isciii.eshttps://repisalud.isciii.es/handle/20.500.12105/15972 HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection D Tarrago, I Gonzalez, MF Gonzalez-Escribano - BMC genomics, 2022 - Springerhttps://link.springer.com/article/10.1186/s12864-022-08689-0 Functional Analysis of the Molecular Factors CG Brooks, G Diamond, MM Millrain, PJ Dyson - J Immunol, 2001 - academia.eduhttps://www.academia.edu/download/90079016/1601.full.pdf Peptide presentation and NK inhibition by HLA-G C Munz , S StevanoviÃâ¡, HG Rammensee - Journal of reproductive , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165037899000297 The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch AA Celik, T Kraemer, T Huyton, R Blasczyk - Immunogenetics, 2016 - Springerhttps://link.springer.com/article/10.1007/s00251-015-0880-z Distinct HLA-E peptide complexes modify antibody-driven effector functions of adaptive NK cells A Rölle , M Meyer, S Calderazzo, D Jager, F Momburg - Cell reports, 2018 - cell.comhttps://www.cell.com/cell-reports/pdf/S2211-1247(18)31187-2.pdfβ-Amyloid Protein Precursor 770 (135-155)
CAS:Beta-Amyloid Protein Precursor 770 (135-155)Aβ Protein Precursor 770 (135-155)Formula:C116H172N35O31S2Purity:98%Color and Shape:SolidMolecular weight:2617.96Protein Kinase C (19-36)
CAS:Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolFormula:C93H159N35O24Molecular weight:2,151.51 g/molH-KAPDNRETL-OH
Peptide H-KAPDNRETL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KAPDNRETL-OH include the following: Cloning, characterization and expression analysis of SIMP (source of immunodominant MHC-associated peptides) in grass carp Ctenopharyngodon idella ZY Xu, P Nie, MX Chang, BJ Sun - Fish & Shellfish Immunology, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1050464807002021 La localisation et la structure de SIMP/STT3-B sont responsables de sa grande contribution aca l'immunopeptidome R Charbonneau - 2006 - papyrus.bib.umontreal.cahttps://papyrus.bib.umontreal.ca/xmlui/bitstream/handle/1866/15314/Charbonneau_Renee_2005_memoire.pdf?sequence=1 Next-generation leukemia immunotherapy K Vincent , DC Roy , C Perreault - Blood, The Journal of the , 2011 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/118/11/2951/28488 The model B6dom1 minor histocompatibility antigen is encoded by a mouse homolog of the yeast STT3 gene K McBride, C Baron, S Picard, S Martin, D Boismenu - Immunogenetics, 2002 - Springerhttps://link.springer.com/article/10.1007/s00251-002-0502-4 CD8 T-cell ability to exert immunodomination correlates with T-cell receptor: epitope association rate G Roy-Proulx, C Baron, C Perreault - Biology of Blood and Marrow , 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1083879105000212 L'immunodominance resulte d'une competition entre les populations lymphocytaires T CD8⺠reconnaissant differents antigacašnes G Roy-Proulx - 2007 - papyrus.bib.umontreal.cahttps://papyrus.bib.umontreal.ca/xmlui/bitstream/handle/1866/15379/Roy-Proulx_Guillaume_2006_these.pdf?sequence=1 The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome E Caron , R Charbonneau, G Huppe - International , 2005 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/17/12/1583/746090 Recognition of allo-peptide is governed by novel anchor imposition and limited variations in TCR contact residues CJA Reinbold, S Malarkannan - Molecular immunology, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589007007432 Mechanisms and Implications of Immunodominance in CD8+ T-Cell Responses C Perreault - Experimental and Applied Immunotherapy, 2011 - Springerhttps://link.springer.com/chapter/10.1007/978-1-60761-980-2_9 Du proteome aca l'immunopeptome: le modacašle SIMP/STT3-B acaâ° Caron - 2005 - papyrus.bib.umontreal.cahttps://papyrus.bib.umontreal.ca/xmlui/bitstream/handle/1866/15267/Caron_Etienne_2004_memoire.pdf?sequence=1H-EVQGFESATFLGYFK-OH
Peptide H-EVQGFESATFLGYFK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EVQGFESATFLGYFK-OH include the following: Application of proteomics in biomarker discovery: a primer for the clinician. V Tambor, A FuÃÂacaÂkova, J LenÃÂo , M Kacerovskacaœ - Physiological , 2010 - biomed.cas.czhttps://www.biomed.cas.cz/physiolres/pdf/59/59_471.pdf Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy RG Saldanha, MP Molloy , K Bdeir - Journal of proteome , 2007 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr060518nH-LLQQFPLDLEK^-OH
Peptide H-LLQQFPLDLEK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LLQQFPLDLEK^-OH include the following: Orthogonal analysis of dystrophin protein and mRNA as a surrogate outcome for drug development K Uaesoontrachoon, S Srinivassane - Biomarkers in , 2019 - Future Medicinehttps://www.futuremedicine.com/doi/abs/10.2217/bmm-2019-0242TBC1D1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TBC1D1 antibody, catalog no. 70R-2415Purity:Min. 95%H-MSSYAFFVQTCR^-OH
Peptide H-MSSYAFFVQTCR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-MSSYAFFVQTCR^-OH include the following: Sample preparation strategies for antibody-free quantitative analysis of high mobility group box 1 protein I Kvivik , G Jonsson, R Omdal , C Brede - Pharmaceuticals, 2021 - mdpi.comhttps://www.mdpi.com/1424-8247/14/6/537 a-Synucleinâ laments bind the transcriptional regulator HMGB-1 EK Lindersson, P Hacaâjrup , WP Gai , D Locker, D Martin - hal.sciencehttps://hal.science/hal-00088420v1/file/Lindersson2004.pdf alpha-Synuclein filaments bind the transcriptional regulator HMGB-1 EK Lindersson, P Hojrup , WP Gai , D Locker - , 2004 - journals.lww.comhttps://journals.lww.com/neuroreport/fulltext/2004/12220/_alpha__Synuclein_filaments_bind_the.9.aspx Identity of nuclear high-mobility-group protein, HMG-1, and sulfoglucuronyl carbohydrate-binding protein, SBP-1, in brain DKH Chou, JE Evans - Journal of , 2001 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1046/j.1471-4159.2001.00209.xZNF169 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF169 antibody, catalog no. 70R-8767Purity:Min. 95%CHRAC1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CHRAC1 antibody, catalog no. 70R-8326Purity:Min. 95%Lysipressin Acetate
Lysipressin Acetate is an analog of vasopressin, a powerful vasopressin used to regulate blood pressure. Endogenous vasopressin in most mammalian species.Formula:C48H68N12O15S2Purity:98%Color and Shape:SolidMolecular weight:1117.26H-SVQEIQATFFYFTPNKTEDTIFLR-OH
Peptide H-SVQEIQATFFYFTPNKTEDTIFLR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SVQEIQATFFYFTPNKTEDTIFLR-OH include the following: Multifucosylated alpha-1-acid glycoprotein as a novel marker for hepatocellular carcinoma K Tanabe , K Kitagawa, N Kojima - Journal of Proteome , 2016 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.5b01145CYP2D6 MS Calibrator (25nmol)
The CYP2D6 MS Calibrator is a peptide that is used for calibrating the mass spectrometer. It is a tryptic peptide and contains an internal standard, which can be used to calculate the concentration of the peptide. The peptides are synthesized using recombinant DNA technology and purified by HPLC.Purity:Min. 95%Tos-Gly-Pro-Arg-ANBA-IPA
CAS:Tos-Gly-Pro-Arg-ANBA-IPA: a substrate for rapid hirudin assay.Formula:C30H41N9O8SPurity:98%Color and Shape:SolidMolecular weight:687.77Secretin-Lys(Biotin), human
Catalogue peptide; min. 95% purityFormula:C130H220N44O40Molecular weight:3,039.4 g/molH-ATVVYQGER-OH
Peptide H-ATVVYQGER-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ATVVYQGER-OH include the following: Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of S Pan, J Rush, ER Peskind, D Galasko - Journal of proteome , 2008 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr700630x Detection and quantification of proteins in clinical samples using high resolution mass spectrometry S Gallien, B Domon - Methods, 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1046202315001218 SI Table 2a b2gpI PBM Score - researchgate.nethttps://www.researchgate.net/profile/Steven-Krilis/publication/293887985_Supplementary_Material_3/links/56d5e36d08aebe4638ac68ca/Supplementary-Material-3.pdf Evaluation of absolute peptide quantitation strategies using selected reaction monitoring J Campbell , T Rezai, A Prakash, B Krastins - , 2011 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.201000511 Detailed method for performing the ExSTA approach in quantitative bottom-up plasma proteomics AJ Percy , CH Borchers - Quantitative Methods in Proteomics, 2021 - Springerhttps://link.springer.com/protocol/10.1007/978-1-0716-1024-4_25 Highly multiplexed targeted proteomics acquisition on a TIMS-QTOF A Lesur , PO Schmit, F Bernardin, E Letellier - Analytical , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.0c03180DLL4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DLL4 antibody, catalog no. 70R-6414Purity:Min. 95%coagulation factor II (thrombin) B chain fragment [Homo sapiens]
Thrombin, a serine protease from the F2 gene, activates clotting by converting fibrinogen to fibrin.Formula:C90H137N23O24SPurity:98%Color and Shape:SolidMolecular weight:1957.26Ac-Ile-Glu-Pro-Asp-AMC
CAS:AMC conjugated molecule targeting caspase-8 and granzyme BFormula:C32H41N5O11Purity:Min. 97 Area-%Color and Shape:PowderMolecular weight:671.7 g/molBis-dPEG®29-Acid
CAS:Bis-dPEG®29-Acid is a PEG polymer categorised as homobifunctional PEG (X-PEG X). Used as a linker, bis-dPEG®29-Acid is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.Formula:C30H49N5O11S3Purity:Min. 95%Molecular weight:751.94 g/molH-SIINFEKL^-OH
CAS:Peptide H-SIINFEKL^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SIINFEKL^-OH include the following: Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters X Lu, JS Gibbs, HD Hickman , A David - Proceedings of the , 2012 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1208696109 Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins TB Fessenden , LE Stopfer , F Chatterjee - for ImmunoTherapy of , 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277371/ Mouse urinary peptides provide a molecular basis for genotype discrimination by nasal sensory neurons T Sturm, T Leinders-Zufall , B MaÃÂek , M Walzer - Nature , 2013 - nature.comhttps://www.nature.com/articles/ncomms2610 Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific T Fifis, P Mottram, V Bogdanoska, J Hanley - Vaccine, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X0400427X of peptide-specific CTL activity and inhibition of tumor growth following immunization with nanoparticles coated with tumor peptide-MHC-I complexes SH Kim, HE Park, SU Jeong, JH Moon, YR Lee - Immune , 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733191/ A modular antigen presenting peptide/oligonucleotide nanostructure platform for inducing potent immune response S Tohumeken , N Gunduz , MB Demircan - Advanced , 2017 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adbi.201700015 Cutting edge: N-hydroxy peptides: a new class of TCR antagonists S Hin, C Zabel, A Bianco , G Jung - The Journal of , 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/163/5/2363/32894 Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and PJ Chefalo, CV Harding - The Journal of Immunology, 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/3/1274/35053 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide P Cascio, C Hilton , AF Kisselev, KL Rock - The EMBO , 2001 - embopress.orghttps://www.embopress.org/doi/full/10.1093/emboj/20.10.2357 Exact prediction of a natural T cell epitope O Rötzschke , K Falk, S Stevanovic - European journal of , 1991 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830211136 Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes NAW Lemmermann , K Gergely, V BoÃËhm - Journal of , 2010 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02087-09 Ovalbumin epitope SIINFEKL self-assembles into a supramolecular hydrogel M Kamalov , H Kahlig, C Rentenberger, ARM Mullner - Scientific Reports, 2019 - nature.comhttps://www.nature.com/articles/s41598-019-39148-8 Tapasin enhances MHC class I peptide presentation according to peptide half-life M Howarth , A Williams, AB Tolstrup - Proceedings of the , 2004 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0306294101 Proteasomes and antigen presentation: evidence that a KEKE motif does not promote presentation of the class I epitope SIINFEKL M Gonciarz-Swiatek, M Rechsteiner - Molecular immunology, 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589005004104 Isolation of processed, H-2Kb -binding ovalbumin-derived peptides associated with the stress proteins HSP70 and GP96 M Breloer , T Marti, B Fleischer - European journal of , 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1521-4141(199803)28:03%3C1016::AID-IMMU1016%3E3.0.CO;2-G Sortase-mediated modification of alphaDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes LK Swee, CP Guimaraes, S Sehrawat - Proceedings of the , 2013 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1214994110 Investigation of antigen delivery route in vivo and immune-boosting effects mediated by pH-sensitive liposomes encapsulated with Kb-restricted CTL epitope KY Lee, E Chun , BL Seong - Biochemical and biophysical research , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X02967112 Both human and mouse cells expressing H-2Kb and ovalbumin process the same peptide, SIINFEKL K Falk, O Rötzschke , S Faath, S Goth, I Graef - Cellular , 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874983712128 MHC/peptide binding studies indicate hierarchy of anchor residues K Deres, W Beck, S Faath, G Jung, HG Rammensee - Cellular immunology, 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874983712281 Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase J Beninga, KL Rock, AL Goldberg - Journal of Biological Chemistry, 1998 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)80196-X/abstract A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway GA Pietersz, W Li, V Apostolopoulos - Vaccine, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X0000373X Detection of Antigen Presentation by Murine Bone Marrow-Derived Dendritic Cells After Treatment with Nanoparticles E Hong, MA Dobrovolskaia - of Nanoparticles Intended for Drug Delivery, 2024 - Springerhttps://link.springer.com/protocol/10.1007/978-1-0716-3786-9_17 Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway DS Pouniotis, V Apostolopoulos , GA Pietersz - Immunology, 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2005.02304.x Comparison of protein and peptide targeting for the development of a CD169-based vaccination strategy against melanoma D Van Dinther , H Veninga, M Revet - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.01997/full Generation of both MHC class I-and class II-restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes D Muno, E Kominami, T Mizuochi - FEBS letters, 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014579300018494 A SIINFEKL-based system to measure MHC class I antigen presentation efficiency and kinetics D Dersh , JW Yewdell , J Wei - Antigen Processing: Methods and Protocols, 2019 - Springerhttps://link.springer.com/protocol/10.1007/978-1-4939-9450-2_9 Defective ribosomal products are the major source of antigenic peptides endogenously generated from influenza A virus neuraminidase BP Dolan, L Li, K Takeda, JR Bennink - The journal of , 2010 - journals.aai.orghttps://journals.aai.org/jimmunol/article/184/3/1419/82278 Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly (I: C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in B Akache, G Agbayani, FC Stark , Y Jia, R Dudani - 2021 - academia.eduhttps://www.academia.edu/download/79316597/pdf.pdf T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo AI Webb , MA Dunstone , NA Williamson - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/175/6/3810/73297 Functional screening of a retroviral peptide library for MHC class I presentation AB Tolstrup, M Duch, I Dalum, FS Pedersen - Gene, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378111900005722 Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more efficiently than protein-loaded cross-presenting DC acaâ Met, S Buus , MH Claesson - Cellular immunology, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S000887490300128X for a novel luminal endoplasmic reticulum aminopeptidase in final trimming of 26 S proteasome-generated major histocompatability complex class I antigenic peptides A Komlosh, F Momburg , T Weinschenk - Journal of Biological , 2001 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)89708-7/abstract pDNA-lipoplexes engrafted with flagellin-related peptide induce potent immunity and anti-tumour effects A Faham, T Herringson, C Parish, A Suhrbier - Vaccine, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X11010772 Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide A Craiu, T Akopian, A Goldberg - Proceedings of the , 1997 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.94.20.10850 Analysis of the proteolytic steps involved in MHC class I presentation of the ovalbumin epitope SIINFEKL A Craiu - 1997 - search.proquest.comhttps://search.proquest.com/openview/dc58025ab6af04f400622af0d7a743d2/1?pq-origsite=gscholar&cbl=18750&diss=y N-hydroxy-amide analogues of MHC-class I peptide ligands with nanomolar binding affinities A Bianco , C Zabel, P Walden - of the European Peptide , 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1099-1387(199812)4:8%3C471::AID-PSC166%3E3.0.CO;2-8 New synthetic non-peptide ligands for classical major histocompatibility complex class I molecules A Bianco , C Brock, C Zabel, T Walk, P Walden - Journal of Biological , 1998 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)59453-4/abstractH-GESA-OH
Peptide H-GESA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GESA-OH include the following: The phosphylated butyrylcholinesterase-derived tetrapeptide GlyGluSerAla proves exposure to organophosphorus agents with enantioselectivity T Kranawetvogl, M Siegert, D Steinritz- Archives of ..., 2024 - Springerhttps://link.springer.com/article/10.1007/s00204-023-03657-3 on O-Glycopeptides: Glycosylation-Induced Conformational Changes of O-GlcNAc, O-LacNAc, O-Sialyl-LacNAc, and O-Sialyl-Lewis-X Peptides of the Mucin W Wu, L Pasternack, DH Huang- Journal of the ..., 1999 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ja983474v Isolation of a tripeptide (Ala-Gly-Ser) exhibiting weak acetylthiocholine hydrolyzing activity from a high-salt soluble form of monkey diaphragm acetylcholinesterase LD Jayanthi , AS Balasubramanian - Neurochemical research, 1992 - Springerhttps://link.springer.com/article/10.1007/BF00974577 Chemical-enzymic synthesis and conformational analysis of sialyl Lewis X and derivatives Y Ichikawa, YC Lin, DP Dumas, GJ Shen- Journal of the ..., 1992 - ACS Publicationshttps://pubs.acs.org/doi/pdf/10.1021/ja00050a007 1H-NMR study of GM2 ganglioside: evidence that an interresidue amide-carboxyl hydrogen bond contributes to stabilization of a preferred conformation SB Levery - Glycoconjugate journal, 1991 - Springerhttps://link.springer.com/article/10.1007/BF00769848 of glycopeptides and its application to a heptacosapeptide-decasaccharide of immunoglobulin G1 Importance of 1-6-glycosidic linkages in carbohydrate · peptide R STUIKE-PRILL, B Meyer - European journal of biochemistry, 1990 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1432-1033.1990.tb19485.xH-DSSEEK-OH
Peptide H-DSSEEK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DSSEEK-OH include the following: Gas phase laser synthesis and processing of calcium phosphate nanoparticles for biomedical applications PV Bapat - 2011 - search.proquest.comhttps://search.proquest.com/openview/1a60b12cbe24e17eb9b1bd862f5c537a/1?pq-origsite=gscholar&cbl=18750 Single-Molecule Force Spectroscopy Reveals Adhesion-by-Demand in Statherin at the Protein-Hydroxyapatite Interface P Steinbauer, A Rohatschek, O Andriotis - Langmuir, 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.langmuir.0c02325 The effect of proteins on hydroxyapatite dissolution M BOLHASSANI - 2012 - politesi.polimi.ithttps://www.politesi.polimi.it/handle/10589/84722 A peptide that inhibits hydroxyapatite growth is in an extended conformation on the crystal surface JR Long , JL Dindot, H Zebroski - Proceedings of the , 1998 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.95.21.12083KCNH6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KCNH6 antibody, catalog no. 70R-5127Purity:Min. 95%NUBP1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NUBP1 antibody, catalog no. 70R-9387Purity:Min. 95%m-dPEG®8-Azide (Azido-m-dPEG®8)
m-dPEG®8-Azide (Azido-m-dPEG®8) is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. m-dPEG®8-Azide (Azido-m-dPEG®8) is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Formula:C20H20F4N2O7Purity:Min. 95%Molecular weight:476.38 g/molKYNU Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KYNU antibody, catalog no. 70R-1261Purity:Min. 95%HXB2 gag NO-19/aa73 - 87
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolMolecular weight:1,775 g/molH-KLTWQELYQLKYKGI-OH
CAS:Peptide H-KLTWQELYQLKYKGI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KLTWQELYQLKYKGI-OH include the following: Designer self-assembling peptide hydrogels to engineer 3D cell microenvironments for cell constructs formation and precise oncology remodeling in ovarian cancer Z Yang, H Xu, X Zhao - Advanced Science, 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/advs.201903718 Vascularized polypeptide hydrogel modulates macrophage polarization for wound healing Z Chen, L Wang, C Guo, M Qiu, L Cheng, K Chen, J Qi - Acta Biomaterialia, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1742706122007279 Designer functionalized self-assembling peptide nanofiber scaffolds for growth, migration, and tubulogenesis of human umbilical vein endothelial cells X Wang, A Horii, S Zhang - Soft Matter, 2008 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2008/sm/b807155a Polymer-peptide Conjugates as Mimetics of Erythropoietin and Vascular Endothelial Growth Factor T Mahon - 2020 - search.proquest.comhttps://search.proquest.com/openview/012a62f6b1d062428c9856566f088184/1?pq-origsite=gscholar&cbl=18750&diss=y A matrix metalloproteinase-responsive hydrogel system controls angiogenic peptide release for repair of cerebral ischemia/reperfusion injury Q Liu, J Xie, R Zhou, J Deng, W Nie, S Sun - Neural Regeneration , 2025 - journals.lww.comhttps://journals.lww.com/nrronline/fulltext/2025/02000/a_matrix_metalloproteinase_responsive_hydrogel.28.aspx Self-assembling peptides: potential role in tumor targeting P Sadatmousavi , M Soltani , R Nazarian - Current , 2011 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpb/2011/00000012/00000008/art00002 Differential effects of a soluble or immobilized VEGFR-binding peptide JT Koepsel, EH Nguyen, WL Murphy - Integrative biology, 2012 - academic.oup.comhttps://academic.oup.com/ib/article-abstract/4/8/914/5204454 Synergistic effects of dual-presenting VEGF-and BDNF-mimetic peptide epitopes from self-assembling peptide hydrogels on peripheral nerve regeneration J Lu, X Yan, X Sun, X Shen, H Yin, C Wang, Y Liu, C Lu - Nanoscale, 2019 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2019/nr/c9nr04521j Biomimetic self-assembling peptide hydrogels for tissue engineering applications J Lu, X Wang - Biomimetic Medical Materials: From Nanotechnology to , 2018 - Springerhttps://link.springer.com/chapter/10.1007/978-981-13-0445-3_18 Enhanced angiogenesis by the hyaluronic acid hydrogels immobilized with a VEGF mimetic peptide in a traumatic brain injury model in rats J Lu, F Guan, F Cui, X Sun, L Zhao - Regenerative , 2019 - academic.oup.comhttps://academic.oup.com/rb/article-abstract/6/6/325/5543860 Multivalent display of chemical signals on self-assembled peptide scaffolds HE Distaffen , CW Jones, BL Abraham - Peptide , 2021 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pep2.24224 Protease-Sensitive, VEGF-Mimetic Peptide, and IKVAV Laminin-Derived Peptide Sequences within Elastin-Like Recombinamer Scaffolds Provide Spatiotemporally F Gonzalez-Perez , M Alonso - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202201646 The powerful functions of peptide-based bioactive matrices for regenerative medicine CM Rubert Perez , N Stephanopoulos , S Sur - Annals of biomedical , 2015 - Springerhttps://link.springer.com/article/10.1007/s10439-014-1166-6 Self-assembling peptide-based hydrogels in angiogenesis C Han , Z Zhang, J Sun , K Li, Y Li, C Ren - International Journal , 2020 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.2147/IJN.S277046 Injectable Peptide Hydrogels Loaded with Murine Embryonic Stem Cells Relieve Ischemia In Vivo after Myocardial Infarction A Roy , L Hao, J Francisco, J Guan, S Mareedu - , 2024 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.biomac.3c01345Formula:C92H143N21O23Molecular weight:1,911.25 g/molPSMA2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PSMA2 antibody, catalog no. 70R-2393Purity:Min. 95%Pancreastatin (1-52), human
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolMolecular weight:5,505.54 g/molH-QTISNACGTIGLIHAIANNK-OH
Peptide H-QTISNACGTIGLIHAIANNK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-QTISNACGTIGLIHAIANNK-OH include the following: Exploring the versatility of the covalent thiol-alkyne reaction with substituted propargyl warheads: a deciding role for the cysteine protease E Mons , RQ Kim , BR van Doodewaerd - Journal of the , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jacs.0c10513Ac-PWRPSHPVWMPT-NH2
Peptide Ac-PWRPSHPVWMPT-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-PWRPSHPVWMPT-NH2 include the following: Receptor mediated uptake of peptides that bind the human transferrin receptor JH Lee, JA Engler, JF Collawn - European journal of , 2001 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1046/j.1432-1327.2001.02073.x Improved gene delivery into neuroglial cells using a fiber-modified adenovirus vector I Joung, G Harber, KM Gerecke, SL Carroll - Biochemical and , 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X05001312 Understanding the transport mechanism of BBB peptide shuttles: THRre and MiniAp-4 as case studies C Fuster Juncaca - 2019 - diposit.ub.eduhttps://diposit.ub.edu/dspace/handle/2445/137497Molecular weight:1,531.8 g/molH-AGQLLSELFTNR-OH
Peptide H-AGQLLSELFTNR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AGQLLSELFTNR-OH include the following: Critical issues and optimized practices in quantification of protein abundance level to determine interindividual variability in DMET proteins by LC-MS/MS proteomics DK Bhatt , B Prasad - Clinical Pharmacology & Therapeutics, 2018 - Wiley Online Libraryhttps://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.819Histone H3 (1-10)
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolC2ORF29 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C2orf29 antibody, catalog no. 70R-4352Purity:Min. 95%H-DEPPQSPWDR-OH
Peptide H-DEPPQSPWDR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DEPPQSPWDR-OH include the following: Conformational adaptation of apolipoprotein AI to discretely sized phospholipid complexes S Bhat, MG Sorci-Thomas, R Tuladhar, MP Samuel - Biochemistry, 2007 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi700384t Clinical application of"omic-sciences"Â to the evaluation of embryo quality: where are we now? L De Toni, M Menegazzo , G Lunardon - Current Trends in , 2016 - scholar.archive.orghttps://scholar.archive.org/work/p537listh5f7pmamws2zgam53u/access/wayback/https://www.cce-online.org/common/php/portiere.php?ID=2cec6f4b736b0357ba204d3427951ec6 The search for biomarkers of human embryo developmental potential in IVF: a comprehensive proteomic approach J Nyalwidhe, T Burch, S Bocca - Molecular Human , 2013 - academic.oup.comhttps://academic.oup.com/molehr/article-abstract/19/4/250/1278623 Protein signature in cerebrospinal fluid and serum of Alzheimer's disease patients: The case of apolipoprotein A-1 proteoforms C Fania, B Arosio , D Capitanio, E Torretta, C Gussago - PloS one, 2017 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0179280 Differential proteomics of the plasma of individuals with sepsis caused by Acinetobacter baumannii AJC Soares, MF Santos, MRO Trugilho - Journal of , 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1874391909002619KCTD21 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KCTD21 antibody, catalog no. 70R-3786Purity:Min. 95%MAP7D1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MAP7D1 antibody, catalog no. 70R-4362Purity:Min. 95%EXOD1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EXOD1 antibody, catalog no. 70R-3112Purity:Min. 95%H-IRPFETKVK-OH
Peptide H-IRPFETKVK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IRPFETKVK-OH include the following: Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope H Ebrahimi-Nik , M Moussa , RP Englander - Nature , 2021 - nature.comhttps://www.nature.com/articles/s41467-021-26646-5 CRISPR-guided reversion reveals the immunogenicity of a"non-MHC binding"Â cancer neoepitope in vivo H Ebrahimi-Nik , M Moussa , R Englander - 2020 - researchsquare.comhttps://www.researchsquare.com/article/rs-119173/latestNLK Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NLK antibody, catalog no. 70R-9450Purity:Min. 95%MYBPC2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MYBPC2 antibody, catalog no. 70R-6055Purity:Min. 95%D-Phenylalanine, methyl ester, hydrochloride
CAS:Formula:C10H14ClNO2Purity:98%Color and Shape:SolidMolecular weight:215.6767H-SGAMSPMSWNSDASTSEAS-OH
Peptide H-SGAMSPMSWNSDASTSEAS-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SGAMSPMSWNSDASTSEAS-OH include the following: Modulatory role of the anti-apoptotic protein kinase CK2 in the sub-cellular localization of Fas associated death domain protein (FADD) V Vilmont, O Filhol , AM Hesse , Y Coute , C Hue - et Biophysica Acta (BBA , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0167488915002633Z-Gln-Gly-OH
CAS:Z-Gln-Gly-OH is a synthetic amino acid. It is an acid conjugate, which is a derivative of the amino acid that has been covalently linked to an organic acid. Z-Gln-Gly-OH is used for the synthesis of recombinant proteins and as a potential drug for the treatment of cancer because it inhibits the enzyme tyrosinase. This product can also be used as a cofactor in enzymatic reactions, such as polymerase chain reactions (PCR) or DNA sequencing. The functional groups on this product are trifluoroacetic acid and hydroxylamine.Formula:C15H19N3O6Purity:Min. 95%Color and Shape:PowderMolecular weight:337.33 g/mol